(3S)-3-(2,2-DIFLUOROETHYL)PYRROLIDINE HYDROCHLORIDE, 95%, 100mg

2-methyl-5-(4-nitrophenyl)-1,3-oxazole, 1g

5-(2,3-dihydro-1,4-benzodioxin-2-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 1g

Methyl 3-amino-5-bromo-4-iodobenzoate, 97.0%, 250mg

2-Amino-5-cyano-N,3-dimethylbenzamide, 95.0%, 100mg

2-Fluoro-1-methylpyridinium p-toluenesulphonate[Mukaiyamas fluorinating agent], 98.0%, 5g

(6R)-3-[(2-chlorophenyl)sulfanyl]-6-[4-(morpholin-4-yl)phenyl]-6-(thiophen-3-yl)piperidine-2,4-dione, 98%, 1mg

3-Amino-1H-indole-2-carboxylic acid ethyl ester, 95.0%, 250mg

6-BROMO-7-METHOXYQUINOLIN-4-OL, 95.0%, 250mg

Dialysis membrane Spectra/Por® Biotech CE MWCO 500–1000, 10 mm, 1 Piece(s)

2-Bromo-5-(trifluoromethyl)pyrimidine, 95.0%, 100mg

2-Chloro-5-methoxypyridin-4-amine, 95.0%, 250mg

MEGA-8, 5 g